Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CENPM | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | RTKN | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
mRNA | SMARCA5 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | EXOSC9 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | CCNA2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | C12orf65 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | ARIH2OS | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | ATP10B | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |